A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
Clinical trial NCT04709276 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04709276
- Sponsor
- Andrew J. Armstrong, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2026-02-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.